TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 133 filers reported holding TRANSLATE BIO INC in Q3 2020. The put-call ratio across all filers is 2.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $951,177,000 | +307.9% | 4,046 | -71.4% | 0.00% | – |
| Q1 2021 | $233,202,000 | +31.3% | 14,142 | +46.8% | 0.00% | – |
| Q4 2020 | $177,573,000 | -18.9% | 9,635 | -40.1% | 0.00% | – |
| Q3 2020 | $218,971,000 | +188.5% | 16,089 | +279.8% | 0.00% | – |
| Q2 2020 | $75,909,000 | -29.0% | 4,236 | -60.5% | 0.00% | – |
| Q1 2020 | $106,898,000 | +224.1% | 10,722 | +164.6% | 0.00% | – |
| Q4 2019 | $32,983,000 | -29.5% | 4,052 | -14.2% | 0.00% | – |
| Q3 2019 | $46,805,000 | +12.6% | 4,723 | +43.5% | 0.00% | – |
| Q2 2019 | $41,578,000 | -34.0% | 3,292 | -46.8% | 0.00% | – |
| Q1 2019 | $63,015,000 | – | 6,184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |